Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. - sprookjes - yvandenbroek - TriplyDB

Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients.

Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients.

http://www.wikidata.org/entity/Q43429238

about

Serological diagnosis of Epstein-Barr virus infection: Problems and solutions Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia.Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments.Comparison of commercial and in-house Real-time PCR assays for quantification of Epstein-Barr virus (EBV) DNA in plasma.Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy.Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye Extranodal natural-killer/t-cell lymphoma, nasal type Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era The impact of plasma Epstein-Barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational study Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma.Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting.Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma.Advances in the medical research and clinical applications on the plasma DNA Variable EBV DNA load distributions and heterogeneous EBV mRNA expression patterns in the circulation of solid organ versus stem cell transplant recipients.Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers.Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases Detection of mutated K-ras DNA in urine, plasma, and serum of patients with colorectal carcinoma or adenomatous polyps.Laboratory assays for Epstein-Barr virus-related disease.Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy.Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma.Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation.Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.Prognostic significance of Epstein-Barr virus DNA in NK/T-cell lymphoma: a meta-analysis.Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.

P2860

Q26829346-C391B5FE-58E8-4449-988C-A11B212059A8 Q30244110-8E7D20DB-1D66-418A-AA6C-2F0DBBA02ACD Q33218405-7F20CD1A-ED35-456B-921D-E18871B1D459 Q33245160-CE1DB973-1D3B-4A7E-A052-DC1683679DE4 Q33280299-3BCD6A21-A6F5-40FD-9661-28726BA7FB6F Q33685029-9FF7A658-63D0-45CE-A29C-AC431B25F6A0 Q34217149-8114092D-F723-49CD-B962-FD8FA976608A Q34479166-6D6AA22A-B3AC-4FF2-826B-648A1BD447CF Q35212779-9535FE24-C422-4CDF-849D-A571FA826707 Q35391282-C1459745-6581-46D0-A12E-3F11E4258DA6 Q35678382-DDCD5AB5-1EF6-4D8B-817A-E429B7B89E0F Q35789774-37129ED2-83B7-4792-BE68-D56C602C2304 Q35807886-97C04A21-C19D-41B3-BC4F-34F1CF3913D6 Q36124331-923FBC8D-803E-4C6B-8D30-04FD5BF2BD42 Q36467468-0AD9E892-FA67-4FA6-A282-8D28BAB7988D Q36508665-4E21DCCA-B8BC-4DFD-8ACA-878BC234F111 Q36537637-32E6BFE0-136C-4D3E-AAE3-B95E9E0E44E6 Q36557585-4555FC80-74FA-4910-B4B4-C07C3DAF100E Q36610034-F7212E6A-9052-4A63-A32F-97D057DA3993 Q36814594-E18EA5F2-F42C-44C2-ABBA-7C5BAC4D0686 Q36825808-1829B3DF-964D-4074-92AE-AB10EFD2F666 Q36983015-5D46C95F-3814-4A1A-BD4F-9AFA710C7277 Q37192117-23F78C87-9B6A-4592-9A47-F73984C2CF4F Q37198986-29BF77E1-350E-4EB2-8168-BEEE8A180C00 Q37301336-779E4950-86B9-4A68-953D-A616B28B60A7 Q37629542-AD8A2DF1-6032-4E7B-A072-3574DDF1F1D7 Q37726624-C9AF0D4F-B9A7-4AA0-A4D9-D8C359434334 Q38270678-84E85F3B-31D6-4544-8C91-0174D1FE9F05 Q39032748-E0CC60F9-BCA3-4E2A-B7D8-C6EBFCB9B427 Q40304324-4311300D-F3BA-459D-91F4-24026E36553F Q53274002-FDA56A99-3AED-4292-B54D-5878B3AA26F5 Q54212216-7263803B-6F62-496C-9B0E-843C8DB2B04F

P2860

Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients.

http://www.wikidata.org/entity/Q43429238

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Molecular characterization of ...... rcinoma and lymphoma patients.

@en

Molecular characterization of ...... rcinoma and lymphoma patients.

@nl

type

label

Molecular characterization of ...... rcinoma and lymphoma patients.

@en

Molecular characterization of ...... rcinoma and lymphoma patients.

@nl

prefLabel

Molecular characterization of ...... rcinoma and lymphoma patients.

@en

Molecular characterization of ...... rcinoma and lymphoma patients.

@nl

P1433

Q43429238-BA435B09-2DBC-4C8A-8349-E6410E705C5D

P1476

Q43429238-6E71D130-471B-4537-BDFF-2559192136A0

P2093

Q43429238-04760FF8-92D8-498A-A79F-DE04919943A3

Q43429238-6282AA8F-1692-4FE6-BC18-E10D07D92FCC

Q43429238-8C0D8B24-6D98-426F-AC52-27541B948222

Q43429238-A751D103-0CB4-4686-9C54-E3D78B2A4170

Q43429238-AD5EAE83-2F6A-4993-A6C2-AEAC2AA1F3CF

Q43429238-C096F9D7-B5C9-4020-B713-1242F28426BB

Q43429238-C41A1B1F-18BE-4CED-92AA-90A18D6E97BD

Q43429238-DEF3CD22-5C23-4C63-8CBB-2B25300A2CD7

P304

Q43429238-053F1DE5-4CD2-4CE3-8150-020E362F53ED

P31

Q43429238-558E4009-4B76-4179-A8BE-A088D7420347

P407

Q43429238-0CB4EC6E-CFBA-40C8-AD58-1948ABBA565E

P433

Q43429238-0E8BF4E9-D6CA-4324-9EDC-2B76B6700D1A

P478

Q43429238-59012A4C-C778-44CC-BC79-C0146F28DC9C

P577

Q43429238-EA6B9030-8E38-4731-A42C-81E1F0F69612

P698

Q43429238-46C4CAA7-4CE1-40C4-B8F6-BC311D8D3A3C

P1433

Cancer Research

P1476

Molecular characterization of ...... rcinoma and lymphoma patients.

@en

P2093

Anthony T C Chan

http://www.w3.org/2001/XMLSchema#string

Jun Zhang

http://www.w3.org/2001/XMLSchema#string

K C Allen Chan

http://www.w3.org/2001/XMLSchema#string

Katherine C K Chow

http://www.w3.org/2001/XMLSchema#string

Kenny I K Lei

http://www.w3.org/2001/XMLSchema#string

Lisa Y S Chan

http://www.w3.org/2001/XMLSchema#string

Sing-Fai Leung

http://www.w3.org/2001/XMLSchema#string

Y M Dennis Lo

http://www.w3.org/2001/XMLSchema#string

P304

2028-2032

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12727814

http://www.w3.org/2001/XMLSchema#string